CINECA IRIS Institutional Research Information System

MAIONE, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.715
EU - Europa 2.443
AS - Asia 1.740
AF - Africa 38
OC - Oceania 22
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 7.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.646
CN - Cina 995
IT - Italia 962
SG - Singapore 270
IE - Irlanda 226
FR - Francia 197
GB - Regno Unito 174
DE - Germania 172
SE - Svezia 158
FI - Finlandia 110
JP - Giappone 101
AT - Austria 86
HK - Hong Kong 69
CA - Canada 61
PL - Polonia 61
UA - Ucraina 61
KR - Corea 55
VN - Vietnam 55
IN - India 47
BE - Belgio 36
ES - Italia 36
ID - Indonesia 35
IL - Israele 33
CH - Svizzera 29
NL - Olanda 29
TW - Taiwan 29
SN - Senegal 26
DK - Danimarca 23
RU - Federazione Russa 19
AU - Australia 18
TR - Turchia 13
GR - Grecia 12
HU - Ungheria 12
BR - Brasile 8
MX - Messico 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
CZ - Repubblica Ceca 6
IR - Iran 6
ZA - Sudafrica 6
LT - Lituania 5
PT - Portogallo 5
AR - Argentina 4
BA - Bosnia-Erzegovina 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
AM - Armenia 3
CO - Colombia 3
IQ - Iraq 3
MY - Malesia 3
NO - Norvegia 3
TH - Thailandia 3
AL - Albania 2
CL - Cile 2
DZ - Algeria 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CY - Cipro 1
GH - Ghana 1
IS - Islanda 1
JO - Giordania 1
MA - Marocco 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 7.983
Salva come PNG Salva come JPEG
Città #
Chandler 346
Ann Arbor 320
Torino 253
Beijing 251
Fairfield 246
Dublin 225
Santa Clara 219
Singapore 206
Houston 167
Ashburn 142
Seattle 119
Woodbridge 118
Wilmington 107
Cambridge 101
Shanghai 96
Dearborn 94
Redwood City 83
Villeurbanne 82
Vienna 80
Guangzhou 79
Nyköping 74
Turin 73
Milan 66
Pisa 65
Princeton 59
Jacksonville 58
Medford 58
Columbus 56
Hangzhou 43
Nanjing 43
Warsaw 42
Fremont 38
Jakarta 35
Rome 34
Dong Ket 33
Los Angeles 32
Tokyo 29
Wuhan 28
Boston 27
Helsinki 27
London 25
San Diego 25
Brussels 22
Chengdu 19
San Francisco 19
Boardman 17
Jinan 17
Taipei 17
Xian 17
New York 16
Changsha 15
Paris 15
Toulouse 15
Munich 14
Phoenix 14
Central 13
Chongqing 13
Dallas 13
Frankfurt am Main 13
Zhengzhou 13
Hong Kong 12
Ottawa 12
Central District 11
Hefei 11
Norwalk 11
Silver Spring 11
Tianjin 11
Chicago 10
Herzliya 10
Moscow 10
New Haven 10
Rehovot 10
Luni 9
Menlo Park 9
Palermo 9
Pittsburgh 9
Simi Valley 9
Trieste 9
Barcelona 8
Duncan 8
Genoa 8
Sassari 8
Shenzhen 8
Toronto 8
Bethesda 7
Birmingham 7
Cincinnati 7
Créteil 7
Falls Church 7
Fuzhou 7
Hebei 7
Lanzhou 7
Lexington 7
Odense 7
Pune 7
Zurich 7
Bari 6
Guiyang 6
Irvine 6
Krakow 6
Totale 4.925
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.945
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 657
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 248
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling 228
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. 205
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. 200
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 197
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 187
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 181
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 170
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 168
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 162
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 159
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. 153
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers 151
Class 3 semaphorins in cardiovascular development 140
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy 127
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth 121
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 120
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 111
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 106
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 99
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 98
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 95
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 93
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 90
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 90
Semaphorins and tumor angiogenesis 81
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 78
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer 76
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 76
Increased Expression of {alpha}6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane 75
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 75
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 75
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 71
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 71
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 69
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy 67
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 66
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 65
Squalenic nanoparticles with active targeting: in vivo results 64
Osteopontin binds ICOSL promoting tumor metastasis 62
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 59
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 58
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner 58
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 55
Targeted nanoparticles for pancreatic cancer. 53
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 53
Targeted nanoparticles for pancreatic cancer. 52
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition 51
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway 51
Nanoparticles targeting pancreatic tumor. 49
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 41
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability 39
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth 39
Design and synthesis of encorafenib-based BRAF-V600E degraders 38
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression 29
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 27
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 26
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 23
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 12
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 11
Totale 8.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.891
article - articoli 0
book - libri 0
conference - conferenze 6.059
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020673 0 0 0 0 0 146 85 93 105 115 76 53
2020/20211.203 63 59 43 86 142 105 94 72 109 134 125 171
2021/20221.322 106 109 85 114 84 100 78 91 79 90 235 151
2022/20231.374 113 124 52 113 119 299 120 84 125 58 102 65
2023/20241.004 85 131 77 91 79 70 74 89 26 72 95 115
2024/2025981 51 109 137 148 398 138 0 0 0 0 0 0
Totale 8.196